FBRX Forte Biosciences Inc
2,663
$0.7101
$0.0399
(5.32%)
| Watchers | 2,663 |
| 52-Wk Low | $0.38 |
| 52-Wk High | $1.11 |
| Market Cap | $27.33M |
| Volume | 6,929.00 |
| 52-Wk High | $1.11 |
| 52-Wk Low | $0.38 |
FY2024 EPS Estimates for Forte Biosciences, Inc. Increased by Analyst (NASDAQ:FBRX)Zolmax • about 1 month ago
Forte Biosciences, Inc. (NASDAQ:FBRX Free Report) Investment analysts at Chardan Capital boosted their FY2024 EPS estimates for shares of Forte Biosciences in a research note issued...
Share to Feed
Forte Biosciences, Inc. (NASDAQ:FBRX Get Free Report) saw unusually large options trading on Wednesday. Traders purchased 30,205 call options on the stock. This is an increase of 1,663...
Forte Biosciences, Inc. (NASDAQ:FBRX Get Free Report) saw unusually large options trading on Wednesday. Stock traders purchased 30,205 call options on the stock. This is an increase of...
Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced its 2023 results and...
Forte Biosciences, Inc. (NASDAQ:FBRX Get Free Report) saw unusually large options trading on Wednesday. Traders purchased 30,205 call options on the stock. This is an increase of 1,663...
Forte Biosciences, Inc. (NASDAQ:FBRX Get Free Report) was the recipient of unusually large options trading on Wednesday. Stock investors purchased 30,205 call options on the company. This is...
Unity Biotechnology (NASDAQ:UBX Get Free Report) and Forte Biosciences (NASDAQ:FBRX Get Free Report) are both small-cap medical companies, but which is the superior stock? We will...